Kathy Hibbs
Chief Administrative Officer presso 23ANDME HOLDING CO.
Patrimonio netto: 1 M $ in data 31/03/2024
Profilo
Kathy L.
Hibbs is currently the Director at Standard BioTools, Inc. since 2024, the Non-Executive Director at SOPHiA GENETICS SA since 2021, the Director at Cadex Genomics Corp.
since 2019, the Chief Administrative Officer at 23andMe, Inc. since 2014, and the Chief Administrative Officer at 23andMe Holding Co. since 2014.
Previously, she worked as the Director-Legal Affairs at Varian Medical Systems, Inc. from 1995 to 1999, as an Independent Director at Veracyte SD, Inc., as an Independent Director at SomaLogic, Inc. from 2023 to 2024, as the Secretary, Senior Vice President & General Counsel at Monogram Biosciences, Inc. from 2000 to 2009, as the Secretary, Senior Vice President & General Counsel at Genomic Health, Inc. from 2009 to 2014, and as the Vice President & General Counsel at Multitude, Inc. from 1994 to 2001.
She holds an undergraduate degree from the University of California, Riverside and a graduate degree from the University of California, Hastings.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
| 18/04/2024 | 1 252 315 ( 0.40% ) | 666 232 $ | 31/03/2024 | |
STANDARD BIOTOOLS INC.
0.03% | 05/01/2024 | 79 412 ( 0.03% ) | 215 207 $ | 31/03/2024 |
SOPHIA GENETICS SA
0.06% | 15/02/2024 | 37 414 ( 0.06% ) | 184 451 $ | 31/03/2024 |
| 10/07/2023 | 50 462 ( 0.03% ) | 26 846 $ | 31/03/2024 |
Posizioni attive di Kathy Hibbs
| Società | Posizione | Inizio |
|---|---|---|
| SOPHIA GENETICS SA | Director/Board Member | 01/03/2021 |
| 23ANDME HOLDING CO. | Chief Administrative Officer | 01/02/2022 |
| STANDARD BIOTOOLS INC. | Director/Board Member | 05/01/2024 |
23andMe, Inc.
 23andMe, Inc. Medical SpecialtiesHealth Technology 23andMe, Inc. provides genetic information using DNA analysis technologies and web-based interactive tools. It enables individuals to gain deeper insights into personal ancestry, genealogy, and inherited traits. The company was founded by Linda Avey, Paul L. Cusenza and Anne E. Wojcicki in 2006 and is headquartered in Sunnyvale, CA. | Chief Administrative Officer | 01/01/2022 |
Cadex Genomics Corp.
 Cadex Genomics Corp. BiotechnologyHealth Technology Cadex Genomics Corp. develops novel blood-based assays for patients with cancer. The company is based in Saint Louis, MO. The company was founded in 2018 by Sudhir Sinha, Bill Haack, Patrick Hall. Bill Haack has been the CEO since 2018. | Director/Board Member | 01/10/2019 |
Precedenti posizioni note di Kathy Hibbs
| Società | Posizione | Fine |
|---|---|---|
| STANDARD BIOTOOLS INC. | Director/Board Member | 05/01/2024 |
| GENOMIC HEALTH, INC. | General Counsel | 01/03/2014 |
Monogram Biosciences, Inc.
 Monogram Biosciences, Inc. Miscellaneous Commercial ServicesCommercial Services Monogram Biosciences, Inc. develops and commercializes diagnostic products for the treatment of human immunodeficiency virus (HIV) infection, hepatitis C virus (HCV) infection, and other viral illnesses, as well as cancer and other diseases. It offers HIV tests, including genotypic, phenotypic, tropism, and combined phenotype and genotype assays, suppression management and viral load testing, HCV assays and oncology tests. The company was founded in 1995 and is headquartered in South San Francisco, CA. | General Counsel | 01/10/2009 |
Multitude, Inc.
 Multitude, Inc. Packaged SoftwareTechnology Services Multitude, Inc. provides software and analytic tools that help government and industry leaders transform data from the emergent. The company was founded by Nick Masson in 2015 and is headquartered in San Francisco, CA. | General Counsel | - |
| ░░░░░░ ░░░░░░░ ░░░░░░░░ ░░░░ | ░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ |
Formazione di Kathy Hibbs
| University of California, Riverside | Undergraduate Degree |
| University of California, Hastings | Graduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 4 |
|---|---|
| STANDARD BIOTOOLS INC. | Health Technology |
| SOPHIA GENETICS SA | Technology Services |
| 23ANDME HOLDING CO. | Health Technology |
| STANDARD BIOTOOLS INC. | Commercial Services |
| Aziende private | 8 |
|---|---|
Varian Medical Systems, Inc.
 Varian Medical Systems, Inc. Medical SpecialtiesHealth Technology Varian Medical Systems, Inc. engages in the manufacture of medical devices and software for treating cancer and other medical conditions. It operates through the Oncology Systems and Proton Solutions segments. The Oncology Systems segment designs, manufactures, sells, and services hardware and software products for treating cancer with conventional radiation therapy, and advanced treatments. The Proton Solutions segment delivers proton therapy, a form of external beam radiotherapy using proton beams for the treatment of cancer. The company was founded by William Hansen, Edward Ginzton, Russell Varian, and Sigurd Varian in 1948 and is headquartered in Palo Alto, CA. | Health Technology |
Monogram Biosciences, Inc.
Monogram Biosciences, Inc. Miscellaneous Commercial ServicesCommercial Services Monogram Biosciences, Inc. develops and commercializes diagnostic products for the treatment of human immunodeficiency virus (HIV) infection, hepatitis C virus (HCV) infection, and other viral illnesses, as well as cancer and other diseases. It offers HIV tests, including genotypic, phenotypic, tropism, and combined phenotype and genotype assays, suppression management and viral load testing, HCV assays and oncology tests. The company was founded in 1995 and is headquartered in South San Francisco, CA. | Commercial Services |
Genomic Health, Inc.
 Genomic Health, Inc. Medical SpecialtiesHealth Technology Genomic Health, Inc. engages in the provision of genomic-based diagnostic tests. Its tests analyze the underlying biology of cancers, allowing physicians and patients to make individualized treatment decisions. The firm uses a platform which translates a massive amount of clinical and genomic data into clinically actionable results for treatment planning. The company was founded by Patrick F. Terry, Joffre B. Baker, Randal W. Scott, and Steven Shak in August 2000 and is headquartered in Redwood City, CA. | Health Technology |
| Granite Bank, FSB (San Francisco, California) | Finance |
23andMe, Inc.
23andMe, Inc. Medical SpecialtiesHealth Technology 23andMe, Inc. provides genetic information using DNA analysis technologies and web-based interactive tools. It enables individuals to gain deeper insights into personal ancestry, genealogy, and inherited traits. The company was founded by Linda Avey, Paul L. Cusenza and Anne E. Wojcicki in 2006 and is headquartered in Sunnyvale, CA. | Health Technology |
Multitude, Inc.
Multitude, Inc. Packaged SoftwareTechnology Services Multitude, Inc. provides software and analytic tools that help government and industry leaders transform data from the emergent. The company was founded by Nick Masson in 2015 and is headquartered in San Francisco, CA. | Technology Services |
Veracyte SD, Inc.
 Veracyte SD, Inc. Miscellaneous Commercial ServicesCommercial Services Decipher Biosciences, Inc. is a commercial-stage precision oncology company which engages in patient care improvement. The Company?s differentiated approach measures the biological activity of a patient?s entire tumor genome, known as whole transcriptome analysis, and applies proprietary machine learning algorithms to improve therapy selection and accelerate adoption of new therapies into the standard of care. Its novel prostate cancer genomic testing products examine the underlying biology of a patient?s tumor, enabling physicians to select an optimal therapy. The firm?s whole transcriptome analysis of clinical patient samples from its commercial channel and its participation in practice-changing clinical trials has allowed it to build and expand its Decipher GRID database GRID. The company was founded by Elai Davicioni, Timothy J. Triche, Bruce A. Schmidt, and Jonathan D. Buckley and is headquartered in San Diego, CA. | Commercial Services |
Cadex Genomics Corp.
Cadex Genomics Corp. BiotechnologyHealth Technology Cadex Genomics Corp. develops novel blood-based assays for patients with cancer. The company is based in Saint Louis, MO. The company was founded in 2018 by Sudhir Sinha, Bill Haack, Patrick Hall. Bill Haack has been the CEO since 2018. | Health Technology |
- Borsa valori
- Insiders
- Kathy Hibbs
